Regulation

FDA Looks Back On Fifty Years of Cannabis Research, Prepares for Growth Ahead

FDA researchers published an article this week titled “From Our Perspective: FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug Development.”

CBD, Congress

Congress Picks Up the Baton from the FDA on CBD, Seeking Data

The unregulated hemp-derived cannabinoid marketplace has exploded since the 2018 Farm Bill descheduled hemp. The FDA has asked Congress to help with a “new regulatory pathway.”

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.

Regulation

CBD’s Potential for Reproductive Harms Among “Big Reasons” Behind FDA’s Punt on Rules

The FDA is seeking a “harm reduction framework” as it works with Congress on a path for CBD, according to the agency’s Cannabis Product Committee lead.